Loading company…
Xregen develops genetic diagnosis and treatment technologies and growth solutions for children.
Xregen develops children's height enhancement solutions, human genetic diagnosis and treatment technologies, and biomedical materials. Its IKids-Growth solution, based on IGF-1, has passed real-world studies. Established in 2022, the company is based in Hangzhou, China. Its Angaosu product launched in November 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in